Summary: This study was undertaken to elucidate the roles of neurons and glial cells in the handling of gluta mate and glutamine, a glutamate precursor, during cere bral ischemia. Slices (400--6 00 fLm) from human neocortex obtained during surgery for epilepsy or brain tumors were incubated in artificial cerebrospinal fluid and subjected to 30 min of combined hypoxia and glucose deprivation (an in vitro model of brain ischemia). These slices, and con trol slices that had not been subjected to "ischemic" con ditions, were then fixed and embedded. Ultrathin sec tions were processed according to a postembedding im munocytochemical method with polyclonal antibodies raised against glutamate or glutamine, followed by colloi dal gold-labeled secondary antibodies. The gold particle densities over various tissue profiles were calculated from electron micrographs using a specially designed computer program. Combined hypoxia and glucose dep rivation caused a reduced glutamate immunolabeling in neuronal somata, while that of glial processes increased. Following 1 h of recovery, the glutamate labeling of neu ronal somata declined further to very low values, com pared to control slices. The glutamate labeling of glial cells returned to normal levels following recovery. In
axon terminals, no consistent change in the level of glu tamate immunolabeling was observed. Immunolabeling of glutamine was low in both nerve terminals and neuronal somata in normal slices and was reduced to nondetectable levels in nerve terminals upon hypoxia and glucose dep rivation. This treatment was also associated with a re duced glutamine immunolabeling in glial cells. Reversed glutamate uptake due to perturbations of the transmem brane ion concentrations and membrane potential proba bly contributes to the loss of neuronal glutamate under "ischemic" conditions. The increased glutamate labeling of glial cells under the same conditions can best be ex plained by assuming that glial cells resist a reversal of glutamate uptake, and that their ability to convert gluta mate into glutamine is compromised due to the energy failure. The persistence of a nerve terminal pool of glu tamate is compatible with recent biochemical data indi cating that the exocytotic glutamate release is contingent on an adequate energy supply and therefore impeded dur ing ischemia. Key Words: Cerebral ischemia-Human cortex-Glutamate-Glutamine-Excitotoxicity-Immu nocytochemistry-Brain slices.
Several lines of evidence suggest that an important role may be played by the amino acid glutamate, which is the most important excitatory neurotrans mitter in mammalian brain as well as an important metabolic intermediate (Fonnum, 1984) . First, glu tamate has neurotoxic properties (Lucas and N ew house, 1957; Olney, 197 1; Olney et aI., 1971; Roth man, 1984; Mayer and Westbrook, 1987) . These are effected through excitatory amino acid receptors and might contribute to neuronal death in several disease states (Olney, 1978; Rothman and Olney, 1986) . Second, studies with in vivo microdialysis have shown a marked increase in the extracellular concentration of glutamate during transient isch emia (Benveniste et aI. , 1984; Hagberg et aI. , 1985; Korf et aI. , 1988) . Third, blockade of glutamate re ceptors alleviates ischemic neuronal death in some animal models (Simon et aI. , 1984; Park et aI. , 1988; Swan et aI. , 1988; Buchan, 1990; Choi, 1990; Shear down et aI. , 1990; Swan and Meldrum, 1990) .
The cellular compartments responsible for the glutamate overflow during ischemia remain to be identified. A precise identification of these sources is a prerequisite for the rational development of strategies to alleviate ischemia-induced glutamate release. One possibility is that glutamate is released Ca 2 + dependently from nerve endings. This notion receives support from the finding that deafferenta tion of hippocampal neurons protects against isch emic neuronal damage (Wieloch et aI. , 1985; Jo hansen et aI. , 1986; J �rgensen et aI. , 1987; Ben veniste et aI., 1989; Kaplan et aI. , 1989; Buchan and Pulsinelli, 1990) . More recent evidence, however, suggests that a Ca 2 + -independent release of nonve sicular glutamate may contribute to the increase in extracellular glutamate concentration during isch emia; indeed, this type of release appears to pre dominate in certain experimental models (KauppiGlU nen et aI. , 1988; Sanchez-Prieto and Gonzales, 1988; Ikeda et aI. , 1989 ; see also Torp et aI. , 1991) . A Ca 2 + -independent release is assumed to reflect a reversal of the glutamate uptake and may in princi ple occur through any neuronal or glial membrane equipped with a glutamate transporter.
The aim of the present study was to examine how combined hypoxia and glucose deprivation (an in vitro model of ischemia) affect the size and distri bution of the intracellular stores of glutamate and glutamine in human neocortical slices. To this end, we have employed a quantitative immunocyto chemical technique that makes it possible to visu alize the cellular and subcellular distribution of amino acids in glutaraldehyde-fixed tissue (Som ogyi et aI. , 1986; Ottersen, 1989a) .
METHODS
Macroscopically normal human neocortex was ob tained from standard lobectomy specimens from five pa tients undergoing surgical treatment for epilepsy (Fal coner, 1979) or gliomas (Walters, 1982 Langmoen and Andersen (1981) and Berg Johnsen and Langmoen (1987) . The tissue was immedi ately immersed in ice-cold artificial cerebrospinal fluid (ACSF) of the following composition (in mM): NaCl, 124; KCI, 2; KH2P04, 1.25; NaHC03, 26; MgS04, 2; CaCI2, 2; and D-glucose, 9. No glutamine was added to the me dium. Within 5 min, thin slices (400-600 j.Lm) were cut by hand perpendicularly to the cortical surface and trans ferred to an incubation chamber of a modified Haas type (Haas et aI., 1979) . The slices were bathed in ACSF (tem perature of 32 ± 2°C, pH 7.4) and superfused by a mixture of 95% O2 and 5% CO2, After 60-135 min, control slices were withdrawn and fixed for 1 h in a solution of 2.5% glutaraldehyde and 1% paraformaldehyde in 0. 1 M phos phate buffer (pH 7.4, room temperature). The remaining slices were subjected to 30 min of combined hypoxia and glucose deprivation, produced by changing to a gas mix ture of 95% N2 and 5% CO2 and ACSF without glucose. The slices were then fixed as described above. In some experiments, some slices were allowed to recover for 1 h with reoxygenation and normal ACSF before fixation.
Immunocytochemistry
Tissue specimens from the immersion-fixed slices were osmicated (1% OS04 in 0.1 M phosphate buffer, pH 7.4), dehydrated in a graded series of ethanols and propylene oxide, and flat embedded in an epoxy resin (Durcupan ACM, Fluka, Buchs, Switzerland). Ultrathin sections (obtained from the superficial part of the slices) were treated according to a postembedding immunogold procedure with a polyclonal antiserum (specifically recogniz ing fixed glutamate or glutamine) followed by a secondary antibody coupled to colloidal gold particles. Detailed de scriptions of the production and characterization of the antisera have been published previously (Storm-Mathisen et aI., 1983; Otters en and Storm-Mathisen, 1984; Laake et al., 1986; Ottersen, 1987 Ottersen, , 1989a Ji et aI., 1991) .
Two protocols were used in the present study: one for labeling of glutamate only, and another for labeling of both glutamate and glutamine in the same section, using secondary antibodies with different gold particle size.
The first protocol was modified from Somogyi and Hodgson (1985) and has been described in detail previ ously (Ottersen, 1987 (Ottersen, , 1989a . Following treatment with 1% HI04 (7 min) and 9% NaHI04 (15 min) to alleviate the masking effect of OS04' the sections were incubated for 2 h in the primary antiserum to glutamate (code no. 03), diluted 1:300 or 1:500. The glutamate antiserum was preadsorbed with glutaraldehyde complexes of aspartate and glutamine (100-200 j.LM and 200-400 j.LM, respec tively). The primary antibodies were detected by incubat ing the sections for 2 h with a secondary antibody (goat anti-rabbit IgG) coupled to colloidal gold particles with a diameter of 15 nm (AuroProbe EM GAR G15, Janssen, Beerse, Belgium). The sections were then stained with 1 % uranyl acetate for 20 min and 1 % lead citrate for 2 min. Sections from control slices, "ischemic" slices, and "recovery" slices were processed in the same drops of immunoreagents, insuring identical treatment.
The second protocol was described in detail by Ot tersen et aI. (1992; see also Rinvik and Ottersen, 1988) . Ultrathin sections were processed for visualization of glu tamate and glutamine by a two-step immunogold proce dure (primary antibody followed by a colloidal gold labeled secondary antibody) essentially as described above, the two incubations being separated by formalde- 
No data
The level of glutamate-like immunoreactivity is expressed by the areal density of gold particles over the different profiles. Nerve cell bodies were recorded from all cell layers, and no attempt was made to differentiate between various nerve cell populations. Only nerve terminals containing round vesicles and establishing asymmetric synaptic contacts with spines were included in the analysis. Values are corrected for particle density over empty resin (0.5-4.9 particies/fLm2 in different experiments). This explains the negative figures encountered in the table. ab c Denote statistically significant difference from preceding value on the same line (ap < 0.001, bp < 0.01, cp < 0.05, Mann-Whitney's U test). When two letters occur in the recovery column, they indicate statistically significant differences from control and ischemia values, respectively. Data from the same cases are represented graphically in Figs. 5 and 6.
hyde vapor treatment of the sections (Wang and Larsson, 1985) . This treatment denatures free anti-IgG binding sites on the first-layer secondary antibody, thereby pre venting interference between the first and second incuba tions (Wang and Larsson, 1985; Ottersen et al., 1992) . The primary antisera to glutamate (code no. 03) or glu tamine (code no. 34) were diluted 1:300 and 1:600, respec tively (case 1), or 1:600 and 1:500, respectively (case 3). The glutamine antiserum was preadsorbed with glutaral dehyde complexes of aspartate (60 JJ-M). The glutamate antiserum was preadsorbed as described above. Gluta mate and glutamine were visualized by 15 and 30 nm gold particles (Amersham, London, U. K.), respectively.
In both protocols, the specificity of the antiserum was
monitored by including test sections containing conju gates of the most abundant amino acids in the brain, as described by Ottersen (1987) . These test sections accom panied the tissue sections throughout the immunocyto chemical procedure. Adsorption controls were performed by adding glutaraldehyde/formaldehyde complexes of glutamate or glutamine to the respective antisera.
Quantitative analysis
The sections were examined and photographed at a pri mary magnification of 6,3OOx in a transmission electron microscope (Philips eM 10, Philips, Eindhoven, The Netherlands). Nerve terminals and glial processes were sampled from the superficial layers (I-III) of the cortex. Only nerve terminals containing round vesicles and es tablishing asymmetric contacts with spines were included in the analysis. Nerve cell bodies were recorded from all cell layers, and no attempt was made to differentiate be tween various nerve cell populations (glutamatergic neu rons are likely to predominate quantitatively). The areas to be photographed were selected randomly at low mag nification (not allowing detection of gold particles) so as to avoid bias.
The quantitative analysis was performed with a spe cially designed computer program (MORFOREL, Black stad et at., 1990). The outlines of cell profiles were en tered from electron micrographs using a Calcomp type 9480 digitizer (Talos System Inc., Scottsdale, AZ, U.S.A.) connected to a Cromemco CS 300 computer (Cromemco Inc., Mountain View, CA, U.S.A.). Gold particle numbers were entered following manual count ing. Statistical evaluation was performed with Mann Whitney's V test for ranked comparisons.
RESULTS

Morphology
Light microscopic examination of semithin sec tions from the tissue specimens revealed that they comprise all layers of the cortex. In most cases, qualitative differences between control sections and "ischemic" sections could easily be recognized at the light microscopic level. The changes seen in "ischemic" tissue included swelling of neuronal so mata, and vacuolization in the neuropil, similar to what has been described as a "Swiss cheese" ap pearance in a recent ultrastructural study of human cerebral contusion (Bullock et aI., 1991) .
Electron microscopic examination of control slices showed good morphological preservation of nerve terminals. Microvacuolization and mitochon drial swelling occurred in some of the nerve cell J Cereb Blood Flow Metab. Vol. 13, No.3, 1993 bodies. In slices subjected to combined hypoxia and glucose deprivation, such changes were widespread and more profound, and were accompanied by swelling of neuronal somata, clumping of chroma tin, detachment of ribosomes from granular endo plasmic reticulum, swelling of glial cell processes, and increased extracellular volume.
Immunocytochemical observations
Specificity. The test sections (Fig. 1) that the different antisera reacted selectively with the appropriate amino acids. Preadsorption of the antisera with the respective antigens completely abolished labeling of test antigens and tissue sec tions (not shown).
Glutamate. In control slices, the gold particle densities were generally high in axon terminals of asymmetric junctions. Cell bodies displayed a wide range of labeling intensities but, as mentioned above, it was considered outside the scope of the present study to correlate the labeling intensity with neuronal classification. The gold particle densities were generally low in glial processes (Table 1) . Following combined hypoxia and glucose depri vation, there was a marked redistribution of gluta mate-like immunoreactivity (Glu-LI), with a decline in the immunolabeling of neuronal somata (Table 1, Figs. 2, 5A , and 6A). With regard to axon terminals, their glutamate content showed no consistent change during "ischemia" (Table 1, Figs. 3 and 5B). Glial cell processes exhibited an increased glu tamate immunolabeling in all five cases with an av erage increase of about 200% (Table 1 , Figs. 4, 5C , and 6B).
In slices that had been allowed to recover under control conditions after combined hypoxia and glu cose deprivation, the Glu-LI in neuronal somata had declined further, compared to slices fixed im mediately after the "ischemic" insult (Table 1, Figs. SA and 6A). The rate of decline was slower in the recovery period than during "ischemia" (Figs. 5A and 6A). In axon terminals, a significant reduc tion in Glu-LI was observed in two of three cases (Table 1, Figs. 3 and 5B). Similarly, in two of three cases, the labeling of glial cells had returned to con trol levels after recovery (Table 1, Figs. 4, 5C , and 6B). The third case was atypical insofar as it showed a very modest response to ischemia (case no. 9, Table O .
Glutamine. The distribution of glutamine was an alyzed in preparations double labeled for glutamate and glutamine (Figs. 2-4 and 7) . The density of gold FIG. 5. Diagrams showing levels of glutamate-like immuno reactivity in neuronal somata (A), axon terminals (B), and glial processes (C) in slices subjected to 30 min of combined hypoxia and glucose deprivation ("ischemia"). In three of the cases, the experiments also included slices allowed to re cover for 60 min after "ischemia." The Y axis indicates the median areal density of gold particles signalling glutamate like immunoreactivity (gold particles/j-Lm 2 ), the solid bar above the X axis indicates the duration of "ischemia," whereas the broken line indicates the duration of recovery where applicable. In the diagrams, the first point for each case is the density value from the slice withdrawn after 60-135 min of preincubation in a physiological solution imme diately before the onset of "ischemia" (see Fig. 6 ), the sec ond point is the value from the slice withdrawn after 30 min of incubation in artificial cerebrospinal fluid without O 2 and glucose, and the third point (for three cases only) is the value from the slice allowed to recover for 60 min. Note the marked reduction in glutamate-like immunoreactivity in neuronal so mata (A) following "ischemia," and the continued decline during recovery. No consistent pattern of change is seen in axon terminals (B). In glial processes, there is an increased glutamate-like immunoreactivity following "ischemia." See noreactivity in neuronal somata in slices subjected to 30 min of combined hypoxia and glucose deprivation ("ischemia"). Same cases as in Fig. SA , but real time. The X axis indicates the time from the start of preincubation, the Y axis indicates the median areal density of gold particles signalling gluta mate-like immunoreactivity (gold particlesij.Lm2), and the solid bar above the X axis indicates the duration of "isch emia." In the diagrams, the first point for each case is the density value from the slice withdrawn immediately before the onset of "ischemia," the second point is the value from the slice withdrawn after 30 min of "ischemia," and the third point (for three cases only) is the value from the slice allowed to recover for 60 min. Note that the patterns of change in glutamate-like immunoreactivity do not seem to be affected by differences in the preincubation time, suggesting that the observed changes are due to the experimentally induced "ischemia" and not to a progressive deterioration of slices with increasing time in the bath. B: Scatter plot of all gold particle counts over glial profiles (pooled data from all cases) showing an increase in glutamate immunolabeling following hypoxia and glucose deprivation. The median increase was from 5.6 �old particlesij.Lm2 in normal slices to 16. 1 gold par ticlesij.Lm (p < 0.001) after "ischemia." Following recovery, the gold particle density fell to a median value of 3.4 part i clesij.Lm 2 (p < 0.001 with respect to "ischemia"). Negative counts in the scatter plot result from the subtraction of back ground immunolabeling over empty resin. Each data point represents the density value for a single glial profile: +, me dian; <>, interquartile range limits. 
DISCUSSION
Methodological considerations
This and a previous study (Torp et al., 1991) rep resent a new approach to the pathophysiology of cerebral ischemia, using a morphological method with a spatial resolution that allows detection of intracellular changes in the distribution of amino acids.
Some variation was noted between the different slice experiments, but this was not surprising con sidering the heterogeneity of the material with re spect to the age of subjects, diagnosis, and site of biopsy. Possible variations in degree and duration of pre chamber hypoxia, and inadvertent fluctua tions in incubation variables, must also be taken into account. The patterns of change in glutamate like immunoreactivity do not seem to be affected by differences in the preincubation time, suggesting that the observed changes are due to the experimen tally induced "ischemia" and not to a progressive deterioration of slices with increasing time in the bath.
Electrophysiological observations from a similar experimental setup with slices from rat hippocam pus show a pronounced depolarization of the mem brane about 2 min after changing the superfusing gas from 95% O 2 /5% CO 2 to 95% N 2 /5% CO 2 , and then a loss of membrane potential within the next 2-4 min (Langmoen and Berg-Johnsen, 1988 ; see also Rader and Lanthorn, 1989) . Upon reoxygenation, a restoration of the membrane potential has been demonstrated in some (Langmoen and Berg-Johnsen, 1988) but not all studies (Rader and Lanthorn, 1989) , indicating that the neurons may preserve their membrane integrity throughout the "ischemic" period depending on the severity of the insult.
In slices subjected to combined hypoxia and glu cose deprivation, there was swelling of neuronal so mata and glial processes. Such volume changes nec essarily affect the gold particle counts. However, the reductions in gold particle densities in neurons are of such a magnitude that they cannot be ac counted for by a simple dilution of the intracellular amino acid pools by the increased water content (see below for other effects of swelling). Further more, glutamate and glutamine showed very differ ent patterns of redistribution, with an actual in crease in Glu-LI in glial cells following hypoxia and glucose deprivation. This attests to the biological relevance of the present observations.
FIG. 7.
Electron micrograph showing two neighboring cells in an ultrathin section from a control slice (case 3) processed according to the double-labeling protocol for glutamate and glutamine. Large particles signal glutamine-like immunoreactivity whereas small particles signal glutamate-like immunoreactivity. The cell to the left (G) is a glial cell while that to the right (N) is a neuron. Note the higher density of small particles over the neuron, and the markedly higher density of large particles over the glial cell, illustrating the different compartmentati ? n of glutamate and glutamine. Bar = 111m.
Redistribution of glutamate
Following 30 min of combined hypoxia and glu cose deprivation, the glutamate immunolabeling of neuronal somata was reduced, while that of glial processes was increased. Interestingly, the gluta mate labeling of the neuronal somata further de clined during recovery. The redistribution of gluta mate seen in the present study corresponds to ob servations in the rat following 20 min of forebrain ischemia, i.e., a reduction in the glutamate concen tration in neuronal somata, an increased glutamate concentration in glial cells, and no significant change in axon terminals (Torp et aI., 1991) .
Although the present study does not provide data about the extracellular concentration of glutamate, it seems likely that the reduced glutamate concen tration in neuronal somata is due to a loss or release of glutamate into the extracellular space. The alter- The level of immunoreactivity is expressed by the areal density of gold particles over the different profiles. Identical sets of profiles were analyzed for both glutamate and glutamine immunolabeling. Values are corrected for particle density (particles/fLm2) over empty resin: 1.3 (case I) and 2.4 (case 3) for glutamate and 0.3 (case I) and 0.9 (case 3) for glutamine. This explains the negative figures encountered in the table. Such values are considered "not detectable" in the text. ab c Denote statistically significant difference from preceding value (ap < 0.001, bp < 0.01, cp < 0.05, Mann-Whitney's U test). When two letters occur in the recovery column, they indicate statistically significant differences from control and ischemia values, respec tively.
native possibility, that glutamate has been con sumed by metabolic processes, seems remote, since the rate of glutamate turnover cannot account for such a dramatic reduction in glutamate concentra tion over a 30-min interval (Erecinska and Silver, 1990) . The membrane depolarization and rise in ex ternal [K +] seen during prolonged ischemia may cause a release of glutamate through reversal of the high-affinity glutamate uptake (Hansen, 1985; Rader and Lanthorn, 1989; Nicholls and Attwell, 1990) .
In addition, ischemia may effect a loss of gluta mate by activating volume-sensitive release mech anisms. Thus, glutamate was released from cultured cerebellar granule cells following a reduction in the osmolarity of the incubation medium (Schousboe et aI., 1990) . Glutamine was released only at very low osmolarity. The release of glutamate was assumed to be coupled to cell swelling, which was also a feature of the present material.
The present observations suggest that neuronal somata contribute to the increased extracellular glu tamate concentration seen during ischemia (Ben veniste et aI., 1984; Hagberg et aI., 1985; Korf et aI., 1988; Mitani et aI., 1991) .
The increased glutamate content of glial pro cesses after hypoxia and glucose deprivation may a priori reflect metabolic perturbations within the glial cells and/or uptake of glutamate from the ex tracellular space. The glial enzyme glutamate syn thetase, which converts glutamate to glutamine, is ATP dependent (Cooper, 1988) . The inhibition of this enzyme during ischemia would allow an accu mulation of glutamate. Our finding of a reduced im munolabeling of glutamine agrees with this interpre tation. Also, the biochemical reaction catalyzed by glutamate dehydrogenase will be affected during ischemia. Thus, during energy failure, the increased [NADH]I[NAD] ratio would favor a reductive am ination of 2-oxoglutarate, i.e., production of gluta mate (Erecinska and Silver, 1990) .
The nons piking properties of glial cells prevent them from undergoing the dramatic electrophysio logical dhanges typical of ischemic neurons (God fraind, 1971; Hansen, 1985; Rader and Lanthorn, 1989; Walz, 1989) . For this reason, it may be ex pected that glutamate uptake will be less affected in glial cells than in neurons. Thus, although the glial uptake will decrease following hypoxia, a net up take may still occur (Nicholls and Attwell, 1990; Attwell et aI., 1991) . This will lead to an accumula tion of glutamate since the glial metabolism of this amino acid is blocked (see above). This metabolic block will be removed upon recovery, permitting an increased uptake, and a rapid fall in the extracellu lar glutamate concentration to physiological levels (Benveniste et al., 1984) .
The present study failed to demonstrate a consis tent pattern of change in the glutamate immunola beling of axon terminals, following hypoxia and glu cose deprivation. This may seem surprising, as pre vious lesion studies indicate that deafferentation of hippocampal neurons may alleviate ischemic cell death (Wieloch et al., 1985; Johansen et al., 1986; J�rgensen et al., 1987; Benveniste et al., 1989; Kaplan et al., 1989; Buchan and Pulsinelli, 1990) . It should be noted in this regard that the average level of Glu-LI in the terminals predominantly reflects the size of the vesicular pool (Ji et al., 1991) . The extravesicular pool is relatively small and changes in the latter might be difficult to detect in our im munocytochemical preparations. Thus, although our findings would argue against a depletion of the vesicular pool, they cannot rule out a loss of ex travesicular glutamate. In fact, recent data suggest that any ischemia-induced release of glutamate from nerve terminals is likely to be of the Ca 2 + independent type (i.e., of cytoplasmic origin), since Ca 2 + -dependent, exocytotic release is severely de pressed during ATP depletion (Kauppinen et al., 1988; Nicholls and Attwell, 1990) . A release of cy toplasmic glutamate (through reversal of uptake) would be compatible with the decreased immunola beling for glutamine. A fall in the cytoplasmic level of glutamate would relieve the strong feedback in hibition of glutaminase (Bradford et al., 1978) , and increase glutamine consumption. The vesicular pool of glutamate is spatially segregated from the glutaminase and would not be expected to interfere with the activity of this enzyme (see, for example, Kvamme and Lenda, 1981) .
CONCLUSIONS
Our findings suggest that neuronal somata con tribute significantly to the increased extracellular concentration of glutamate observed during isch emia (Benveniste et al., 1984; Hagberg et al., 1985; Korf et al., 1988; Mitani et al., 1991) . In contrast, it appears that glutamate accumulates in glial cells fol lowing glucose deprivation and hypoxia. This might reflect reduced enzymatic conversion of glutamate to 2-oxoglutarate and glutamine and a continued up take of glutamate into glial cells when neurons have become incapable of such.
